Eyenovia

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Eyenovia and other ETFs, options, and stocks.

About EYEN

Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes.

CEO

Michael M. Rowe

CEOMichael M. Rowe

Employees

Employees45

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2014

Founded2014

Employees

Employees45

EYEN Key Statistics

Market cap

98.64M

Market cap98.64M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

235.73K

Average volume235.73K

High today

$2.85

High today$2.85

Low today

$2.55

Low today$2.55

Open price

$2.84

Open price$2.84

Volume

293.41K

Volume293.41K

52 Week high

$3.39

52 Week high$3.39

52 Week low

$1.50

52 Week low$1.50

EYEN News

Yahoo Finance 5d

Eyenovia Showcases Microdose Array Print (MAP™) Technology at CES 2023 in Las Vegas - Yahoo Finance

In the Digital Health and Startups category at the 2023 Consumer Electronics Show (CES), Eyenovia showcased its Microdose Array Print (MAP™) Technology, the fir...

EYEN Earnings

-$0.24

-$0.13

-$0.01

$0.10

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 27, After Hours

ActualExpected Mar 27, After Hours